Characteristics of the Studies in the Systematic Review and Meta-Analysis
| Author/Year | Research Design | Sample Size (T/C) | Age Range | Subject Type | Intervention Design (T/C) | Exercise Prescription | Evaluation Tools/Content |
|---|---|---|---|---|---|---|---|
| Holmgren,201025 | RCT | 15/16 | ≥55 | stroke patient | HIIT/control group | 60 minutes/times, 7/week, 5 weeks | SF-36 |
| Munari, 201826 | RCT | 8/7 | 18 to 75 | stroke patient | HIIT/control group | 60 minutes/times, 3/week, 12 weeks | SIS |
| Sandberg,201627 | RCT | 29/27 | ≥50 | stroke patient | HIIT/control group | 60 minutes/times, 2/week, 12 weeks | EQ-5 Days |
| Immink, 201428 | RCT | 12/13 | 32 to 85 | stroke patient | MBT/control group | 130 minutes/times, 1/week, 10 weeks | SIS |
| Kim, 201529 | RCT | 11/11 | 53.45 ± 11.54 | stroke patient | MBT/control group | 40 minutes/times, 3/week, 6 weeks | SF-36 |
| Schmid, 201230 | RCT | 37/10 | 60.2 ± 8.9 | stroke patient | MBT/AET | 60 minutes/times, 2/week, 8 weeks | SS-QOL |
| Song, 202131 | RCT | 16/18 | 57.18 ± 10.65 | stroke patient | MBT/control group | 40 minutes/times, 2/week, 12 weeks | SS-QOL |
| Surbala, 201332 | RCT | 12/11 | 57 ± 5.2 | stroke patient | MBT/control group | 45 minutes/times, 3/week, 8 weeks | SS-QOL |
| Yuen, 202116 | RCT | 29/29 | 63.1 ± 10.6 | stroke patient | MBT/control group | 50 minutes/times, 3/week, 8 weeks | SS-QOL |
| Zhao, 202233 | RCT | 11/15 | 62.98 ± 10.85 | stroke patient | MBT/control group | 40 minutes/times, 2/week, 12 weeks | SS-QOL |
| Matsumoto, 201634 | RCT | 60/60 | 62.4 ± 10.7 | stroke patient | UE/control group | 40 minutes/times, 2/week, 8 weeks | SF-36 |
| Park, 201035 | RCT | 10/10 | 51.80 ± 14.46 | stroke patient | UE/control group | 30 minutes/times, 4/ week, 6 weeks | SF-8 |
| Cano-Mañas, 202036 | RCT | 23/25 | 65.68 ± 10.39 | stroke patient | VRT/control group | 35 minutes/times, 3/week, 8 weeks | EQ-5 Days |
| De Rooij, 202137 | RCT | 28/24 | 57 to 70 | stroke patient | VRT/AET | 30 minutes/times, 2/week, 6 weeks | SS-QOL |
| Park, 202338 | RCT | 20/20 | 62.5 ± 4.7 | stroke patient | VRT/control group | 30 minutes/times, 5/week, 8 weeks | SS-QOL |
| Rodríguez-Hernández, 202139 | RCT | 23/20 | 62.6 ± 13.5 | stroke patient | VRT/control group | 50 minutes/times, 5/week, 3 weeks | EQ-5 Days |
| Zheng, 201540 | RCT | 58/54 | 65.4 ± 13.5 | stroke patient | VRT/control group | 30 minutes/times, 6/week, 4 weeks | SF-36 |
| Chen, 201541 | RCT | 16/15 | 67.16 ± 11.9 | stroke patient | RT/control group | 30 minutes/times, 5/week, 4 weeks | SF-36 |
| Aidar, 201642 | RCT | 11/11 | 51.7 ± 8.0 | stroke patient | RT/control group | 45 minutes/times, 3/week, 12 weeks | SF-36 |
| Gordon, 201343 | RCT | 64/64 | 64.9 ± 11.1 | stroke patient | AET/control group | 40 minutes/times, 3/week, 12 weeks | SF-36 |
| Hyun, 202144 | RCT | 15/15 | 61.47 ± 11.08 | stroke patient | AET/VRT | 30 minutes/times, 3/week, 8 weeks | SS-QOL |
| Langhammer, 200845 | RCT | 32/32 | 71.4 ± 13.5 | stroke patient | AET/control group | 40 minutes/times, 1/week, 12 weeks | SS-QOL |
| Mayo, 201346 | RCT | 44/43 | 67.7 ± 14.4 | stroke patient | AET/control group | 30 minutes/times, 2/week, 12 weeks | SS-QOL |
| Park, 201747 | RCT | 13/13 | 65.68 ± 10.39 | stroke patient | AET/control group | 40 minutes/times, 3/week, 4 weeks | SS-QOL |
| Studenski, 200548 | RCT | 40/40 | 74.0 ± 10.4 | stroke patient | AET/control group | 40 minutes/times, 3/week, 12 weeks | SIS |
Notes: Intervention Group (T); Control Group (C); Randomized controlled trial (RCT); High Intensity Interval Training (HIIT); Mind-Body Training/control group (MBT); Underwater Exercise (UE); Virtual Reality Training (VRT); Resistance Training (RT); Aerobic Exercise Training (AET); Mental Component Scale (SF-36); European Quality of Life 5 Dimensions (EQ-5 Days); Stroke-specific Quality of Life (SS-QOL); Stroke Impact Scale (SIS); SF-8 health survey.